Kiniksa Pharmaceuticals Ltd.
(NASDAQ : KNSA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.10%38.130.9%$1129.43m
JNJJohnson & Johnson 0.22%148.330.7%$849.83m
MRKMerck & Co., Inc. 0.35%83.830.7%$650.71m
BMYBristol-Myers Squibb Co. -0.19%63.121.0%$626.06m
ABBVAbbVie, Inc. 0.29%94.961.9%$618.17m
AZNAstraZeneca Plc -1.25%55.111.2%$544.71m
LLYEli Lilly & Co. -0.66%149.471.1%$400.24m
NVSNovartis AG -0.79%84.700.2%$152.14m
GSKGlaxoSmithKline Plc -1.49%40.580.2%$132.39m
MISTMilestone Pharmaceuticals, Inc. -1.72%8.590.0%$118.05m
OPKOPKO Health, Inc. -0.62%4.8311.2%$113.92m
NVONovo Nordisk A/S -0.92%65.740.1%$70.64m
RGENRepligen Corp. -1.92%143.457.1%$68.01m
PRNBPrincipia Biopharma, Inc. -2.21%89.770.0%$56.80m
SNYSanofi -2.03%50.330.2%$54.21m

Company Profile

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, KPL-716, KPL-045, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Hamilton, Bermuda.